| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Revenue | $3.66B | +15.6% |
| Cost of Revenue | $1.08B | +13.5% |
| Gross Profit | $2.58B | +16.5% |
| R&D Expense | $963.3M | +19.8% |
| SG&A Expense | $318.4M | +11.2% |
| Operating Income | $114.8M | +34.7% |
| Pre-tax Income | $224.3M | +51.7% |
| Income Tax | $36.1M | -12.1% |
| Net Income | $188.2M | +76.3% |
| EPS (Basic) | $0.57 | +72.7% |
| EPS (Diluted) | $0.55 | +77.4% |
| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Cash & Equivalents | $854.9M | +18.1% |
| Accounts Receivable | $944.8M | +38.8% |
| Inventory | $75.9M | +77.4% |
| Current Assets | $3.06B | +19.3% |
| Total Assets | $4.67B | +17.9% |
| Current Liabilities | $1.91B | +19.6% |
| Total Liabilities | $3.23B | +21.5% |
| Stockholders' Equity |
| Line Item | 2026-02-01 | Y/Y |
|---|---|---|
| Operating Cash Flow | $880.1M | +16.8% |
| Capital Expenditures | $264.3M | +16.6% |
| Investing Cash Flow | -$108.1M | +50.5% |
| Financing Cash Flow | -$644.8M | -26.5% |
| Free Cash Flow | $615.7M | +16.9% |
| $1.45B |
| +10.7% |